CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with ...
Plus Therapeutics Inc. (NASDAQ:PSTV) jumped 60% in premarket trading Thursday following news of a national agreement with UnitedHealthcare Insurance Company (NYSE:UNH) covering its CNSide® ...
The CNSide ® CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases. The superior clinical utility of CNSide ® over ...
Investing.com -- Plus Therapeutics Inc (NASDAQ:PSTV) stock surged 60% in premarket trading Thursday after the company ...
CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics (PSTV), announced that it has signed a national agreement with UnitedHealthcare ...
Plus Therapeutics, Inc. (NASDAQ: PSTV) shares went skyward Thursday, on word its CNSide Diagnostics, subsidiary of Plus Therapeutics, Inc. has signed a national agreement with UnitedHealthcare ...